These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27088631)

  • 1. Using In Vitro High-Throughput Screening Data for Predicting Benzo[k]Fluoranthene Human Health Hazards.
    Burgoon LD; Druwe IL; Painter K; Yost EE
    Risk Anal; 2017 Feb; 37(2):280-290. PubMed ID: 27088631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prioritizing chemicals of ecological concern in Great Lakes tributaries using high-throughput screening data and adverse outcome pathways.
    Corsi SR; De Cicco LA; Villeneuve DL; Blackwell BR; Fay KA; Ankley GT; Baldwin AK
    Sci Total Environ; 2019 Oct; 686():995-1009. PubMed ID: 31412529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.
    Wetmore BA; Wambaugh JF; Ferguson SS; Sochaski MA; Rotroff DM; Freeman K; Clewell HJ; Dix DJ; Andersen ME; Houck KA; Allen B; Judson RS; Singh R; Kavlock RJ; Richard AM; Thomas RS
    Toxicol Sci; 2012 Jan; 125(1):157-74. PubMed ID: 21948869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating Publicly Available Data to Generate Computationally Predicted Adverse Outcome Pathways for Fatty Liver.
    Bell SM; Angrish MM; Wood CE; Edwards SW
    Toxicol Sci; 2016 Apr; 150(2):510-20. PubMed ID: 26895641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse outcome pathways during early fish development: a conceptual framework for identification of chemical screening and prioritization strategies.
    Volz DC; Belanger S; Embry M; Padilla S; Sanderson H; Schirmer K; Scholz S; Villeneuve D
    Toxicol Sci; 2011 Oct; 123(2):349-58. PubMed ID: 21750347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of in vitro HTS-derived concentration-response data as biological descriptors improves the accuracy of QSAR models of in vivo toxicity.
    Sedykh A; Zhu H; Tang H; Zhang L; Richard A; Rusyn I; Tropsha A
    Environ Health Perspect; 2011 Mar; 119(3):364-70. PubMed ID: 20980217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of fit-for-purpose assays within tiered testing approaches: A case study evaluating prioritized estrogen-active compounds in an in vitro human uterotrophic assay.
    Beames T; Moreau M; Roberts LA; Mansouri K; Haider S; Smeltz M; Nicolas CI; Doheny D; Phillips MB; Yoon M; Becker RA; McMullen PD; Andersen ME; Clewell RA; Hartman JK
    Toxicol Appl Pharmacol; 2020 Jan; 387():114774. PubMed ID: 31783037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.
    Rotroff DM; Wetmore BA; Dix DJ; Ferguson SS; Clewell HJ; Houck KA; Lecluyse EL; Andersen ME; Judson RS; Smith CM; Sochaski MA; Kavlock RJ; Boellmann F; Martin MT; Reif DM; Wambaugh JF; Thomas RS
    Toxicol Sci; 2010 Oct; 117(2):348-58. PubMed ID: 20639261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying Compounds with Genotoxicity Potential Using Tox21 High-Throughput Screening Assays.
    Hsieh JH; Smith-Roe SL; Huang R; Sedykh A; Shockley KR; Auerbach SS; Merrick BA; Xia M; Tice RR; Witt KL
    Chem Res Toxicol; 2019 Jul; 32(7):1384-1401. PubMed ID: 31243984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating Pathway-Specific From Nonspecific Effects in High-Throughput Toxicity Data: A Foundation for Prioritizing Adverse Outcome Pathway Development.
    Fay KA; Villeneuve DL; Swintek J; Edwards SW; Nelms MD; Blackwell BR; Ankley GT
    Toxicol Sci; 2018 Jun; 163(2):500-515. PubMed ID: 29529260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on the use of alternative species in human health and ecological hazard assessments.
    Perkins EJ; Ankley GT; Crofton KM; Garcia-Reyero N; LaLone CA; Johnson MS; Tietge JE; Villeneuve DL
    Environ Health Perspect; 2013 Sep; 121(9):1002-10. PubMed ID: 23771518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Points of Departure for Health Risk Assessment Based on High-Throughput Screening Data.
    Sand S; Parham F; Portier CJ; Tice RR; Krewski D
    Environ Health Perspect; 2017 Apr; 125(4):623-633. PubMed ID: 27384688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Transcriptomics Screen of ToxCast Chemicals in U-2 OS Cells.
    Bundy JL; Everett LJ; Rogers JD; Nyffeler J; Byrd G; Culbreth M; Haggard DE; Word LJ; Chambers BA; Davidson-Fritz S; Harris F; Willis C; Paul-Friedman K; Shah I; Judson R; Harrill JA
    Toxicol Appl Pharmacol; 2024 Oct; 491():117073. PubMed ID: 39159848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative in vitro-to-in vivo extrapolation in a high-throughput environment.
    Wetmore BA
    Toxicology; 2015 Jun; 332():94-101. PubMed ID: 24907440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing.
    Wetmore BA; Allen B; Clewell HJ; Parker T; Wambaugh JF; Almond LM; Sochaski MA; Thomas RS
    Toxicol Sci; 2014 Nov; 142(1):210-24. PubMed ID: 25145659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to advancing quantitative human health risk assessment of environmental chemicals in the post-genomic era.
    Chiu WA; Euling SY; Scott CS; Subramaniam RP
    Toxicol Appl Pharmacol; 2013 Sep; 271(3):309-23. PubMed ID: 20353796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.